AVITA Medical (NASDAQ:RCEL) reported quarterly earnings results on February 12, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.38, beating the consensus estimate of $-0.47 by $0.09 per share. Revenue came in at $17.6M, missing the estimate of $25.2M.
AVITA Medical's stock moved following the earnings release. The stock currently trades at $4.16 with a market capitalization of $94.5M.